Literature DB >> 27789030

Spatiotemporal Programing for the On-Demand Release of Bupivacaine Based on an Injectable Composite Hydrogel.

Van Vuong Dinh1, Yun-Suhk Suh2, Han-Kwang Yang3, Yong Taik Lim4.   

Abstract

We report a programed drug delivery system that can tailor the release of anesthetic bupivacaine in a spatiotemporally controlled manner. The drug delivery system was developed through the combination of a collagen-based injectable hydrogel and 2 types of poly(lactic-co-glycolic acid) (PLGA) particles. As a rapid-release platform (90% release after 24 h), bupivacaine hydrochloride was incorporated into collagen/poly(γ-glutamic acid) hydrogel, which exhibited gel formation at body temperature. PLGA microparticles (diameter 1-3 μm) containing bupivacaine base showed a very slow release of bupivacaine (95% after 240 h), whereas PLGA nanoparticles (124 ± 30 nm) containing bupivacaine base demonstrated an intermediate release rate (95% after 160 h). By changing the relative composition ratio between the 3 components in these injectable composite hydrogels, the release of bupivacaine could be easily controlled from very rapid (within 1 day) to very delayed (up to 9 days). The experimental results on the release data (cumulative release, time point release, average release rate) were coincident with the release profile generated by computer simulation. These injectable composite hydrogels with systematically tunable mixing ratios are expected to serve as a promising technology for the on-demand release of bupivacaine in pain management.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  controlled release; hydrogels; microparticles; nanoparticles; simulations

Mesh:

Substances:

Year:  2016        PMID: 27789030     DOI: 10.1016/j.xphs.2016.09.020

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides.

Authors:  Xiao Kuang; Shuang Zhou; Weiling Guo; Zhenjie Wang; Yanhui Sun; Hongzhuo Liu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

2.  Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere.

Authors:  Wenjing Zhang; Cong Ning; Weiguo Xu; Hanze Hu; Mingqiang Li; Guoqing Zhao; Jianxun Ding; Xuesi Chen
Journal:  Theranostics       Date:  2018-05-23       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.